Methods |
Study design: parallel group randomised trial. Study dates: not available. Setting: not available. Country: South Korea. |
|
Participants |
Inclusion criteria: not available. Exclusion criteria: not available. Sample size: 30. Age: not available. Sex: men. |
|
Interventions |
Group 1 (n = not available): radiofrequency. Group 2 (n = not available): 'placebo therapy.' Cointerventions: not available. |
|
Outcomes |
Prostatitis symptoms How measured: NIH‐CPSI and Pelvic Pain Symptoms Survey. Time points measured: baseline, and 1 month after treatment. Time points reported: only P value of 1 month after treatment. |
|
Funding sources | None. | |
Declarations of interest | Not available. | |
Notes | We extracted this information from an abstract presentation. We contacted the authors: Dr Oh (mamah@hanmail.net) and Dr Bae (urobae@genetherapy.or.kr) and they mentioned that there was no publication available. | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Abstract only. |
Allocation concealment (selection bias) | Unclear risk | Abstract only. |
Blinding of participants and personnel (performance bias) Subjective outcomes | Unclear risk | Abstract only. |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Abstract only. |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Abstract only. |
Selective reporting (reporting bias) | Unclear risk | Abstract only. |
Other bias | Unclear risk | Abstract only. |